Skip to main content

In Vitro Technologies Awarded US Patent

Premium
In Vitro Technologies has been awarded US Patent 7,351,584, “Hepatocyte bioreactor system for long term culture of functional hepatocyte spheroids.”
 
The inventors listed on the patent are Paul Silber, Nancy Cowger, Ana Miller, Lanika Brown, and Albert Li.
 
According to the abstract, a rotating wall vessel is used as a culture vessel and bioreactor for the cultivation of spheroid hepatocytes that retain many properties of the intact liver. These properties include enzyme activity comparable to fresh cells and long-term maintenance of viability and cellular function for periods as long as several months. The cultured cells may be used to produce hepatocyte products, evaluate the metabolism of potential drug candidates, propagate the hepatitis C virus, and test candidate compounds as inhibitors of this virus.

The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.